Underlying factors relating to acute myocardial infarction for coronary artery ectasia patients
Qianqian Sheng1, Huiqiang Zhao, Shanshan Wu
1Department of Cardiology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing, China.
Insights
Coronary artery ectasia patients with a history of acute myocardial infarction (AMI) and higher inflammation markers face increased AMI risk. Lower antiplatelet use and poor lipid control also contribute to AMI incidence in these patients.
Area of Science:
- Cardiology
- Vascular Biology
- Internal Medicine
Background:
- Coronary artery ectasia (CAE) is associated with a higher incidence of acute myocardial infarction (AMI).
- Understanding factors contributing to AMI in CAE patients is crucial for risk stratification and management.
- Previous studies have not fully elucidated the specific risk factors for AMI in the context of CAE.
Purpose of the Study:
- To investigate the underlying factors associated with the development of AMI in patients diagnosed with CAE.
- To compare clinical characteristics, cardiovascular risk factors, inflammatory markers, and coronary imaging features between CAE patients with and without AMI.
Main Methods:
- A case-control study involving 119 patients with CAE diagnosed between 2016-2017.
- Comparison of disease history, cardiovascular risk factors, thrombotic and inflammatory status, and coronary imaging characteristics between 32 AMI patients and 87 non-AMI patients.
- Logistic regression analysis to identify independent predictors of AMI in CAE patients.
Main Results:
- CAE patients who developed AMI had a lower rate of antiplatelet use, higher low-density lipoprotein cholesterol (LDL-C) levels, increased neutrophil-to-lymphocyte (NL) ratio, higher Gensini scores, and a greater proportion of Markis type II ectasia.
- Logistic regression identified AMI history, lower antiplatelet rate, higher NL ratio, higher LDL-C, higher Gensini score, and Markis type II as significant predictors of AMI in CAE patients.
Conclusions:
- AMI history, reduced antiplatelet treatment, poor lipid control, extensive coronary stenosis, elevated inflammatory response (higher NL ratio), and Markis type II ectasia are closely linked to AMI incidence in CAE patients.
- These findings highlight the importance of aggressive risk factor management, including antiplatelet therapy and lipid control, in CAE patients to prevent AMI.
- Further research may focus on the specific mechanisms linking Markis type II ectasia and inflammation to AMI in this population.
Abstract:
Coronary artery ectasia (CAE) patients were more prone to present with acute myocardial infarction (AMI), this case-control research aimed to explore the underlying factors relating AMI for them.This study investigated a serial of 119 patients who underwent coronary angiography and were diagnosed as CAE between the years 2016 and 2017 at the Beijing Friendship Hospital; 32 of the patients developed AMI and 87 did not develop AMI. The possible factors relating to AMI, including disease history, cardiovascular risk factors, thrombotic condition, inflammation status, and coronary imaging characteristics, were comprehensively compared between CAE patients with and without AMI.CAE patients with AMI had a lower antiplatelet rate, a higher blood low-density lipoprotein cholesterol level, increased neutrophil to lymphocyte (NL) ratio, higher Gensini score, and larger proportions of Markis type II. Logistic regression analysis also indicated that AMI history, lower antiplatelet rate, higher NL ratio, higher low-density lipoprotein cholesterol level and Gensini score, as well as Markis type II were associated with AMI in CAE patients.AMI history, lower antiplatelet treatment rates, poor blood lipid control and higher coronary stenosis extent, higher inflammatory response, and Markis type II were closely related to the incidence of AMI in CAE patients.
More Related Videos
06:39Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome I: Introduction
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:30Coronary Artery Disease I: Introduction
01:30Coronary Artery Disease III: Clinical Manifestations
01:26Coronary Artery Disease II: Pathophysiology